References
- 1Stern JS. Tourette’s syndrome and its borderland. Practical neurology. 2018; 18(4): 262–270. DOI: 10.1136/practneurol-2017-001755
- 2Billnitzer A, Jankovic J. Current management of tics and tourette syndrome: behavioral, pharmacologic, and surgical treatments. Neurotherapeutics. 2020; 17: 1681–1693. DOI: 10.1007/s13311-020-00914-6
- 3Roessner V, Plessen KJ, Rothenberger A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011; 20: 173–196. DOI: 10.1007/s00787-011-0163-7
- 4Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019; 92(19): 896–906. DOI: 10.1212/WNL.0000000000007466
- 5Kanaan AS, Jakubovski E, Müller-Vahl K. Significant tic reduction in an otherwise treatment-resistant patient with Gilles de la Tourette syndrome following treatment with nabiximols. Brain sciences. 2017; 7(5): 47. DOI: 10.3390/brainsci7050047
- 6Sandyk R, Awerbuch G. Marijuana and Tourette’s syndrome. J Clin Psychopharmacol. 1988; 8(6): 444–445. DOI: 10.1097/00004714-198812000-00021
- 7Trainor D, Evans L, Bird R. Severe motor and vocal tics controlled with Sativex®. Australas Psychiatry. 2016; 24(6): 541–544. DOI: 10.1177/1039856216663737
- 8Bundesinstitut für Arzneimittel und Medizinprodukte. Bundesoptiumstelle – Cannabis als Medizin Website.
https://www.bfarm.de/DE/Bundesopiumstelle/Cannabis/_node.html . - 9Jakubovski E, Müller-Vahl K. Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients. Int J Mol Sci. 2017; 18(8): 1739. DOI: 10.3390/ijms18081739
- 10Curtis A, Clarke CE, Rickards HE. Cannabinoids for Tourette’s Syndrome. Cochrane Database Syst Rev. 2009; 2009(4): CD006565. DOI: 10.1002/14651858.CD006565.pub2
- 11Jakubovski E, Pisarenko A, Fremer C, et al. The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders. Front Psychiatry. 2020; 11: 575826. DOI: 10.3389/fpsyt.2020.575826
- 12Morgan CJ, Schafer G, Freeman TP, et al. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected] [correction appears in Br J Psychiatry. 2010; 197(5): 416]. Br J Psychiatry. 2010; 197(4): 285–290. DOI: 10.1192/bjp.bp.110.077503
- 13GW Pharmaceuticals. Sativex Product Monograph. Salisbury, Wiltshire, UK; 2010.
- 14Baron EP. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It’s Been …. Headache. 2015; 55(6): 885–916. DOI: 10.1111/head.12570
- 15Lal S, Shekher A, Puneet, et al. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacol Res. 2021; 163: 105302. DOI: 10.1016/j.phrs.2020.105302